RobertLouisWongMD
Rheumatology • New Brunswick, NJRheumatologist, Robert Wood Johnson University Medical Group
Are you Dr. Wong?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
125 Paterson St
Ste 5100
New Brunswick, NJ 08901Phone+1 732-235-6583Fax+1 732-235-7238
Summary
- Dr. Robert Wong, MD is a rheumatologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey. He is affiliated with Robert Wood Johnson University Hospital and is a Rheumatologist at Robert Wood Johnson University Medical Group.
Education & Training
University of ConnecticutFellowship, Rheumatology, 1983 - 1989
Albany Medical CenterResidency, Internal Medicine, 1980 - 1983
Tufts University School of MedicineClass of 1980
Certifications & Licensure
NJ State Medical License 1990 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 300 citationsAssessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.Désirée van der Heijde, David Salonen, Barbara N. Weissman, Robert Landewé, Walter P. Maksymowych
Arthritis Research & Therapy. 2009-08-24 - 629 citationsEfficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.Désirée van der Heijde, Alan Kivitz, Michael Schiff, Joachim Sieper, Ben A. C. Dijkmans
Arthritis and Rheumatism. 2006-07-01 - 198 citationsAdalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)P. J. Mease, P Ory, John T. Sharp, Christopher T. Ritchlin, F. Van den Bosch
Annals of the Rheumatic Diseases. 2009-05-01
Press Mentions
3 AC&R Study Summaries: Fractures in Patients with SSc, Clinical Response in JIA, & TV & the Public Perception of GoutAugust 16th, 2023
Professional Memberships
- Fellow
